Sparkline无形价值主动型ETF ITAN 深 沪
等待开盘 05-14 09:30:00 美东时间
40.0855
+0.034
+0.09%
华盛通- 最 高40.155
- 今 开39.96
- 成交量 2945股
- 最 低 39.9201
- 昨 收 40.0513
- 总市值 8177.44万
- 52周最高 40.68
- 市盈率 静 --
- 换手率 0.14%
- 52周最低 30.1903
- 委 比 0.00%
- 总股本 204.00万
- 历史最高 40.68
- 量 比 0.74
- 振 幅 0.59%
- 历史最低 17.5926
- 每 手 1
- 风险率 2.62%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Seaport Entertainment targets mid-2027 Pier 17 event space opening while keeping $70M-$90M Seaport capex plan
Earnings Call Insights: Seaport Entertainment Group (SEG) Q1 2026 Management view "To start the year, we completed the sale of 250 Water Street, generating more than $75 million of liquidity and elimi...
05-08 10:02
CK San-Etsu Streamlines Copper Operations via Simplified Subsidiary Merger
The latest update is out from CK San-Etsu Co., Ltd. ( ($JP:5757) ). CK San-Etsu...
04-21 15:23
Ateme partners with Nvidia on Apple Vision Pro immersive video workflows
Ateme partners with Nvidia on Apple Vision Pro immersive video workflows Ateme entered a collaboration with Nvidia to develop immersive video workflows for live Apple Immersive experiences on Apple Vision Pro. Workflows combine Ateme TITAN video processing platform with NEA streaming origin to suppo
04-14 15:53
阿斯利康(AZN)股票3月30日开盘上涨5.70%：原因全解读
• 阿斯利康股价受 tozorakimab 治疗慢性阻塞性肺病 (COPD) 试验的积极结果推动而上涨。 • Tozorakimab 达到了主要终点，能够减少 COPD 病情的恶化。 • 分析师预计其峰值销售额将达到 30-50 亿美元，并上调了 AZN 的评级。
03-30 13:50
AstraZeneca PLC Stock (AZN) Opened Up by 5.70% on Mar 30: Key Drivers Unveiled
• AstraZeneca's share price rose on positive tozorakimab COPD trial results. • Tozorakimab met primary endpoints, reducing COPD exacerbations. • Analysts project $3-5 billion peak sales, upgrading AZN ratings.
03-30 13:49
Market-Moving News for March 27th
U: 18% | Unity Software shares are trading higher after the company issued preliminary Q1 2026 revenue guidance that exceeded its earlier outlook AZN: 3% | AstraZeneca shares are trading higher after the
03-27 19:18
AstraZeneca Says Tozorakimab Cuts COPD Flare-Ups In Phase 3 Trials
Positive high-level results from the Phase III OBERON and TITANIA trials in patients with chronic obstructive pulmonary disease (COPD) showed that tozorakimab reduced the annualised rate of moderate-to-severe COPD
03-27 19:14
BRIEF-Saga Metals Acquires Strategic Titanium Assets From Rio Tinto In Quebec
BRIEF-Saga Metals Acquires Strategic Titanium Assets From Rio Tinto In Quebec Saga Metals Corp SAGA.V : SAGA METALS ACQUIRES STRATEGIC TITANIUM ASSETS FROM RIO TINTO IN QUEBEC Source text: ID:nGNX6wR6QL Further company coverage: SAGA.V
03-26 20:52
BRIEF-General Mills To Sell Its Business In Brazil
BRIEF-General Mills To Sell Its Business In Brazil March 17 (Reuters) - General Mills Inc GIS.N : GENERAL MILLS TO SELL ITS BUSINESS IN BRAZIL GENERAL MILLS - DEAL INCLUDES YOKI AND KITANO, EXPECTED TO CLOSE BY END OF 2026 GENERAL MILLS: ENTERED INTO A DEFINITIVE AGREEMENT TO SELL ITS BUSINESS IN BR
03-17 19:52
Ateme Signs Multi-Year TITAN Live Transcoder Deal With Netflix
Ateme Signs Multi-Year TITAN Live Transcoder Deal With Netflix ATEME SA has signed a multi-year agreement with Netflix to deploy its TITAN Live transcoder to support Netflix’s live streaming workflows. The software enables real-time, bandwidth-efficient encoding across multiple codecs and is designe
03-03 16:46
